Presentations
|
|
16 October 2010 |
Presentation at the 9th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment Development of AUS-131 (S-equol) as an Oral Agent for Menopausal Symptoms and Benign Prostatic Hyperplasia
|
8 October 2010 |
Presentation of results from two Phase 1 trials at The North American Menopause Society 21st Annual Meeting Development of S-equol, a Natural, Selective Estrogen Receptor β (ERβ) Agonist for the Treatment of Menopausal Symptoms
|
25 January 2010 |
Presentation at the 7th Annual BIO Asia International Partnering Conference Presentation 7th Bio Asia Conference
|
22 June 2009 |
Presentation of preclinical data for AUS-131 at the Endocrinology Society Annual Meeting S-Equol Prevents Hot Flushes and Prostate Hypertrophy in Animal Models
|
19 May 2009 |
Presentation at Bio 2009 International Convention Development of a First-in-Class Selective Estrogen Receptor-β Agonist AUS-131
|
10 NOVEMBER 2008 |
Presentation at the 8th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment S-equol: Preclinical Studies Supporting its Use as aPharmaceutical Agent.
|
25 July 2008 |
Presentation at the 2nd Polyphenol Meeting Recent Progress of Equol Science |
© 2009 Ausio Pharmaceuticals, LLC |